Q4 Results_ Lupin ED On Earnings & FY23 Projections

Higher input and freight costs along with impairments weighed on Lupin as the drugmaker posted a surprise loss. In conversation with ED Ramesh Swaminathan on growth strategies and outlook for FY23. #BQLive #Q4WithBQ